R. Shirakawa

Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure.

S. Kinugawa, N. Kakutani, S. Takada, 2019, European journal of pharmacology.

Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction

T. Anzai, I. Yokota, S. Kinugawa, 2020, Cardiovascular Diabetology.

Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice

S. Kinugawa, N. Kakutani, S. Takada, 2021, BMC pharmacology & toxicology.

Impaired mitochondrial oxidative phosphorylation capacity in epicardial adipose tissue is associated with decreased concentration of adiponectin and severity of coronary atherosclerosis

F. Dela, T. Nakajima, Y. Matsui, 2019, Scientific Reports.

Mitochondrial reactive oxygen species generation in blood cells is associated with disease severity and exercise intolerance in heart failure patients

F. Dela, T. Nakajima, T. Anzai, 2019, Scientific Reports.

Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance.

T. Nakajima, H. Sabe, T. Anzai, 2020, Cardiovascular research.

Impact of High Respiratory Exchange Ratio During Submaximal Exercise on Adverse Clinical Outcome in Heart Failure.

T. Anzai, S. Kinugawa, K. Okita, 2018, Circulation journal : official journal of the Japanese Circulation Society.

Enhanced mitochondrial oxidative metabolism in peripheral blood mononuclear cells is associated with fatty liver in obese young adults

H. Sabe, I. Yokota, S. Hashino, 2023, Scientific Reports.

Correlation between increased atrial expression of genes related to fatty acid metabolism and autophagy in patients with chronic atrial fibrillation

Y. Matsui, Y. Shingu, Tomonori Ōoka, 2019, bioRxiv.